Long intergenic non-protein coding RNA 2022 (LINC02022)

Long intergenic non-protein coding RNA 2022 (LINC02022) is a member of the lincRNA (long intergenic non-coding RNA) class, a type of long non-coding RNA (lncRNA) more than 200 nucleotides in length and not translated into protein[3][1]. LINC02022 is annotated as a non-coding RNA gene and does not overlap with protein-coding genes[1][3]. Its expression and biological function are not well characterized in the literature, and there is no evidence it is a direct therapeutic target, receptor, or enzyme. Generally, lincRNAs as a class can regulate transcription, influence chromatin state, and modulate the activity of other RNAs (like microRNAs), with some members implicated in cellular processes such as cell proliferation, cell death, and tumorigenesis[3][5][7]. For LINC02022 specifically, there is currently no established role in disease or as a biomarker, and no known interacting drugs or therapeutic safety concerns[1][5]. Note: The information above reflects the general properties of the lincRNA class; no specific disease association or therapeutic target status is documented for LINC02022 in the current search results.

Other names

LINC02022long intergenic non-protein coding RNA 2022